Sanyuan Biology announced that it intends to participate as an intended investor in the capital increase project of Sinoma Synthetic Crystals Research Institute (Shandong) Company, with a proposed investment amount of no more than 30 million yuan. Sinoma Synthetic Crystals Research Institute (Shandong) Company plans to raise no more than 200 million yuan through capital increase and share expansion, focusing on the infrared optical materials and products industry. Its main products include multispectral CVD zinc sulfide, elemental-grade zinc sulfide, CVD zinc selenide, hot-pressed magnesium fluoride and other special infrared optical materials, which are widely used in infrared imaging, photoelectric detection, security monitoring, intelligent driving and other fields. Sanyuan Biology said that this investment is based on the steady development of its core main business, further deepening its layout in the field of optical materials and devices, and cultivating a medium- and long-term second growth curve for the company.
Shandong Sanyuan Biotechnology Co.Ltd.Plans to invest up to 30 million yuan in Sinoma Synthetic Crystals, expanding into optical materials.
Plans to raise up to 200 million yuan via capital increase for infrared optical materials.
